Pilot Study: PARP1 Imaging in Advanced Prostate Cancer.
Farrokh DehdashtiMelissa A ReimersKooresh I ShoghiDelphine L ChenJingqin LuoBuck RogersRussell K PachynskiSreeja SreekumarCody WeimholtDong ZhouPublished in: Molecular imaging and biology (2022)
FTT-PET/CT may serve as an alternate biomarker for PARP1 expression and a potential method for PARPi treatment selection.